TITLE

Current Treatment Options for Waldenström Macroglobulinemia

AUTHOR(S)
Vijay, Arun; Gertz, Morie A.
PUB. DATE
December 2008
SOURCE
Clinical Cancer Update;Dec2008, Vol. 2 Issue 1, p71
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Waldenström macroglobulinemia (WM) is a lymphoma characterized by lymphoplasmacytic bone marrow infiltration and elevated immunoglobulin M levels. Effective treatment modalities exist for this disease but no cure. We review available treatment modalities, the findings of relevant and comparative recent clinical trials, and the latest therapeutic advances in the management of patients with WM. Alkylating agents, nucleoside analogues, monoclonal antibodies, and proteasome inhibitors have been studied as single therapeutic agents and as combination therapies. The encouraging results of combination regimens have resulted in their use as first-line and salvage treatments. Further clinical trials are required before a specific regimen can be recommended.
ACCESSION #
43593348

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics